By Shobha Shukla & Bobby Ramakant
A 20-hospital, 3-year ICMR research of over 150,000 sufferers finds that carbapenem drug-resistant infections are driving up each deaths and remedy prices
A big multi-centre research of over 150,000 sufferers in India’s 20 tertiary-care hospitals has put a stark quantity on one of many high ten world well being threats immediately: Antimicrobial Resistance (AMR). AMR occurs when infections simpler to deal with earlier turn out to be troublesome (or not possible) to deal with as a result of disease-causing microbes (reminiscent of micro organism, virus, fungi, parasites) turning into drug resistant.
The findings provide one of many clearest multi-centre photos but of the medical and financial burden when frequent Gram-negative micro organism turn out to be immune to carbapenem antibiotics.
And the message is blunt: AMR will not be merely making infections more durable to deal with. It’s translating into extra deaths and considerably increased remedy prices.
Researchers in contrast outcomes amongst sufferers contaminated with 4 main Gram-negative pathogens – Escherichia coli (E. coli), Klebsiella pneumoniae (Okay. pneumoniae), Acinetobacter baumannii (A. baumannii) and Pseudomonas aeruginosa (P. aeruginosa) – trying particularly at infections that have been drug-resistant or prone to carbapenem antibiotics. Carbapenem antibiotics are a robust group of broad-spectrum antibiotics, upon which clinicians have historically relied on when infections brought on by Gram-negative micro organism turn out to be immune to different medication. Resistance to those medicines subsequently leaves medical doctors with fewer therapeutic choices.
E.coli is a standard reason for urinary and bloodstream infections; Okay. pneumoniae could cause pneumonia, urinary infections and sepsis; A. baumannii is especially related to critically in poor health hospital sufferers; and P. aeruginosa could cause extreme infections in folks with extended hospital publicity or underlying sickness.
The research authored by Dr Kamini Walia, Dr Sonam Vijay, Dr Nitin Bansal, et al, printed in The Lancet Regional Health – Southeast Asia (Volume 53, October 2026), analysed knowledge from 20 tertiary-care hospitals throughout India between April 2022 and April 2025. Dr Kamini Walia serves as a senior scientist at Indian Council of Medical Analysis (ICMR), heads its Descriptive Analysis Division and leads ICMR on Antimicrobial Resistance (AMR).
Every of the 20 collaborating hospitals was required to designate a minimal of 150 inpatient beds for Antimicrobial Resistance (AMR) surveillance actions, together with a minimum of 50 intensive care unit (ICU) beds and 100 ward beds.
“All sufferers have been adopted up till their ultimate medical consequence (discharge from the hospital or loss of life),” notes the research.
“Carbapenem drug-resistant infections brought about considerably increased mortality and remedy prices than prone infections. Mortality was notably excessive in bloodstream infections, reaching 46–51% for carbapenem drug-resistant Acinetobacter, Pseudomonas and Klebsiella,” posted Dr Kamini Walia on LinkedIn. “For India, the research highlights the necessity to transfer past drug resistance surveillance to built-in surveillance linking AMR with affected person outcomes, whereas strengthening an infection prevention, proper and well timed diagnostics, antimicrobial stewardship and entry to efficient newer antibiotics.”
A nationwide snapshot of a rising menace
The size of the surveillance effort is critical.
Researchers examined information from 159,336 hospitalised sufferers within the 20 tertiary-care hospitals, representing greater than 1.75 million patient-days of hospital care. “Affected person-days” measures the full variety of days all admitted sufferers spend in a hospital or healthcare facility over a selected interval.
Of those sufferers, 27,283 had infections confirmed microbiologically, whereas 26,213 (16.4% of the complete hospitalised inhabitants studied) had Gram-negative bacterial infections.
Amongst these with Gram-negative infections, greater than six in ten have been immune to carbapenem antibiotics, in keeping with the research’s evaluation.
Mortality rose throughout all 4 micro organism
For each main pathogen examined, sufferers with carbapenem drug-resistant infections confronted a better danger of loss of life than these contaminated with carbapenem prone strains.
The distinction was notably putting for E. coli and P. aeruginosa. Sufferers with carbapenem-resistant E. coli had a 41% increased relative danger of loss of life than these with prone infections. For P. aeruginosa, the corresponding improve was 43%.
For Okay. pneumoniae, the relative danger was 33% increased, whereas carbapenem-resistant A. baumannii was related to a 16% increased relative danger.
Absolute mortality knowledge underline the severity
In line with the research’s reported outcomes, mortality was 24.4% for carbapenem-resistant E. coli in contrast with 17.3% for prone infections. For Okay. pneumoniae, mortality was 31.2% versus 23.5%. A. baumannii had notably excessive mortality general: 37.9% amongst resistant infections in contrast with 32.8% amongst prone infections. For P. aeruginosa, the corresponding figures have been 28.9% and 20.2%.
It is very important observe that bloodstream infections can quickly progress to sepsis and multi-organ failure, leaving little room for delays or ineffective remedy. Essentially the most alarming knowledge appeared in bloodstream infections brought on by carbapenem drug-resistant non-fermenting micro organism, principally A. baumannii and P. aeruginosa. Mortality in these instances reached 46% to 51%.
AMR additionally comes with a monetary penalty
The research didn’t cease at mortality.
Researchers additionally examined size of hospitalisation and antibiotic remedy prices. Drug-resistant infections required costlier remedy, with antibiotic prices 1.1 to 2 instances increased than these related to prone infections.
As soon as first-line or generally used antibiotics not work, clinicians might have newer, costlier medication or mixtures of antibiotics. Sufferers may additionally require longer hospital stays, intensive monitoring and extra complicated (and could also be costlier) care.
For hospitals already working beneath stress, these prices accumulate shortly.
The research discovered, for instance, that sufferers with carbapenem-resistant E. coli had a mean hospital keep of about 23 days, in contrast with about 18 days amongst sufferers with prone E. coli infections. Nevertheless, size of hospital keep was carbapenem-resistant A. baumannii and P. aeruginosa was shorter, which may very well be due to excessive mortality. “This paradox doubtless displays the early mortality in carbapenem-resistant A. baumannii and P. aeruginosa infections, resulting in decreased size of hospital keep owing to poor survival,” notes the research.
In different phrases, drug resistance can create a vicious cycle: the an infection turns into more durable to deal with, remedy turns into extra difficult, hospitalisation can turn out to be longer, and prices rise whereas the affected person’s danger of dying will increase.
The altering antibiotic arsenal
The researchers additionally checked out how clinicians have been treating drug-resistant infections.
For carbapenem-resistant E. coli and Okay. pneumoniae, ceftazidime–avibactam was used extra generally than polymyxin B, reflecting the altering therapeutic panorama for difficult-to-treat Gram-negative infections.
However the availability of newer antibiotics doesn’t get rid of the underlying downside.
Each new antibiotic launched into medical apply exists inside an evolutionary contest. Micro organism that survive publicity can purchase or choose for resistance mechanisms, probably eroding the usefulness of medicine that have been as soon as thought-about dependable.
That makes antimicrobial stewardship – the trouble to make sure antimicrobials (like antibiotics, antivirals, antifungals and anti-parasitics) are used solely when applicable, and that, after proper and well timed analysis, the best drug is given on the proper dose and for the best length. This isn’t merely a prescribing precept however turns into a central a part of preserving the effectiveness of the remaining remedy choices.
Why well being surveillance is indispensable
A lot of the obtainable proof on AMR comes from laboratory surveillance, which might present whether or not micro organism remoted from sufferers are immune to specific antibiotics. However understanding that drug resistance exists is totally different from understanding what it does to sufferers in real-life hospital settings throughout a various nation like India.
The brand new research hyperlinks microbiological drug resistance to outcomes reminiscent of mortality, hospitalisation and remedy prices throughout a big multi-centre inhabitants.
That distinction is essential in India, the place researchers have pointed to fragmented surveillance, incomplete laboratory and medical knowledge and an absence of standardised estimates of mortality related to resistant infections.
Was an infection acquired within the healthcare facility?
The research discovered that 85% of E. coli infections have been healthcare-associated infections (or hospital acquired), 91.6% of Okay. pneumoniae infections have been healthcare-associated, 95.1% of A. baumannii infections have been healthcare-associated, and 91.9% of P. aeruginosa infections have been healthcare related. “Amongst blood stream related infections throughout all pathogens, once more majority (greater than 85%) have been categorized as healthcare-associated infections,” notes the research.
These findings level past antibiotic prescribing alone.
“Microbiologically confirmed infections have been categorized as community-acquired if the tradition was optimistic inside 48 hours of hospitalisation and there was no historical past of hospitalisation inside the previous 90 days. Infections not assembly these standards have been categorized as healthcare-associated infections,” research authors clarify.
An infection prevention as essential as new antibiotics
If drug-resistant infections are concentrated in healthcare settings, then stopping them within the first place turns into as essential as discovering higher medication to deal with them.
The researchers in the end name for stronger surveillance, higher an infection prevention and management, improved entry to efficient therapies and stronger antimicrobial stewardship.
The implications prolong from intensive-care models to hospital laboratories and pharmacy departments.
Hand hygiene, environmental cleansing, applicable use of invasive gadgets utilized in medical procedures, speedy identification of drug-resistant organisms (proper and well timed analysis and drug-susceptibility testing the place potential), isolation or cohorting the place applicable, and cautious antibiotic prescribing, all type a part of the efforts to save lots of us from drug-resistant infections.
So does well being surveillance.
A hospital can’t successfully management a drug-resistant organism it can’t detect or monitor. Authorities of India’s prestigious Indian Council of Medical Analysis (ICMR)’s AMR Surveillance Programme led by Dr Kamini Walia has made pathbreaking contributions through the years to determine patterns and measure whether or not AMR interventions are working.
The brand new multi-year research was itself funded by way of an ICMR task-force mission.
A warning, not a verdict
The findings are highly effective, however they shouldn’t be learn as proof that drug resistance alone brought about each loss of life.
Individuals with drug-resistant infections could differ from these with prone infections in essential methods, together with underlying illness, severity of sickness, prior antibiotic publicity and healthcare-associated danger components. These variations can affect outcomes independently of drug resistance itself.
The researchers’ comparability nonetheless supplies sturdy proof of an affiliation between carbapenem drug resistance and worse outcomes throughout a number of main pathogens.
And the consistency is troublesome to disregard.
The research authors observe: “Many of the hospitals, included within the research have very excessive requirements of an infection management and are accredited by nationwide and worldwide high quality management boards, however they’re tertiary care hospitals, which predominantly handle referred and critically in poor health sufferers; subsequently, the charges noticed shouldn’t be interpreted as indicators of hospital efficiency. We suspect that hospitals with poor laboratory help to facilitate well timed identification and remedy could have far worse affected person outcomes in contrast to what’s documented on this research.”
For the well being system, this research is one other reminder that stopping drug-resistance – and stopping infections from spreading within the first place – could in the end be far less expensive than attempting to outrun micro organism after drug-resistance has emerged.
“Lastly, bettering entry to newer efficient antimicrobials is essential to scale back mortality related to drug resistant infections in India,” suggest research authors.
ICMR researcher Dr Sonam Vijay rightly shared on LinkedIn that “Our findings amongst 1.5 lakh (150,000) hospitalised sufferers, together with 16.4% with Gram-negative bacterial infections, spotlight the necessity for well timed diagnostics and entry to efficient, inexpensive novel antimicrobials to enhance outcomes and cut back the financial burden of carbapenem-resistant infections.”
(The writers are a part of CNS Editorial group in addition to on the board of International AMR Media Alliance)
